Bookmark Saya

DOAJ Open Access 2022

P1104: A PHASE 1 STUDY EVALUATING SAFETY AND EFFICACY OF PARSACLISIB IN COMBINATION WITH BENDAMUSTINE + OBINUTUZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA (CITADEL-102)

M. Hamadani M. Coleman R. Boccia J. Duras M. Hutchings +7 lainnya
Lihat Sumber DOI

Topik & Kata Kunci

Diseases of the blood and blood-forming organs

Penulis (12)

M

M. Hamadani

M

M. Coleman

R

R. Boccia

J

J. Duras

M

M. Hutchings

P

P. L. Zinzani

R

R. Cordoba

M

M. B. Oreiro

V

V. Williams

M

M. Stouffs

P

P. Langmuir

J

J.-M. Sancho

Format Sitasi

APA MLA BibTeX
Hamadani, M., Coleman, M., Boccia, R., Duras, J., Hutchings, M., Zinzani, P.L. et al. (2022). P1104: A PHASE 1 STUDY EVALUATING SAFETY AND EFFICACY OF PARSACLISIB IN COMBINATION WITH BENDAMUSTINE + OBINUTUZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA (CITADEL-102). https://doi.org/10.1097/01.HS9.0000847284.03476.7b

Akses Cepat

PDF tidak tersedia langsung

Cek di sumber asli →
Lihat di Sumber doi.org/10.1097/01.HS9.0000847284.03476.7b
Informasi Jurnal
Tahun Terbit
2022
Sumber Database
DOAJ
DOI
10.1097/01.HS9.0000847284.03476.7b
Akses
Open Access ✓